Clinical Trials Logo
  1. Home
  2. Acute on Chronic Hepatic Failure
  3. NCT01079091

Hepa Wash Treatment of Patients With Acute-on-Chronic Liver Failure in Intensive Care Units — HEPATICUS-1  

Acute on Chronic Hepatic Failure Clinical Trial

Official title:
Hepa Wash Treatment of Patients With Acute-on-Chronic Liver Failure in Intensive Care Units

Clinical Trial Summary

Patients with compensated chronic liver disease who have an episode of acute deterioration of liver function (acute-on-chronic liver failure) are known to have up to 90% mortality rate. Hepa Wash(R) is a newly developed liver and renal support system that is based on the use of recycled albumin dialysate. The new system has shown a high detoxification capacity in in-vitro and preclinical studies. The aim of the study is to evaluate the safety and efficacy of the Hepa Wash system in patients with acute-on-chronic liver failure in the intensive care unit.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01079091
Study type Interventional
Source Hepa Wash GmbH
Contact
Status Terminated
Phase N/A
Start date September 2010
Completion date October 2013
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT05989958 - The Safety and Tolerability Study of HepaCure in Chinese Subjects With Acute-On-Chronic Liver Failure Phase 1
Recruiting NCT03773887 - Comparison of Inflammatory Profiles and Regenerative Potential in Alcoholic Liver Disease N/A
Terminated NCT01937130 - Pharmacokinetic and Pharmacodynamic Study of IDN-6556 in ACLF Phase 2
Recruiting NCT01698723 - A Trial of Ribavirin in Patients With ACLF Due to Hepatitis E Virus Phase 2
Active, not recruiting NCT02833064 - Biomarkers in Liver Failure
Completed NCT00764049 - Single Pass Albumin Dialysis in Patients With Cirrhosis Phase 1/Phase 2
Completed NCT01383460 - Efficacy of Granulocyte Colony-stimulating Factor and Erythropoetin for Patients With Acute-on-chronic Liver Failure Phase 3
Recruiting NCT05030571 - The Effects of Double Plasma Molecular Adsorption System in Acute on Chronic Liver Failure Patients N/A
Terminated NCT02857010 - Allogenic Bone Marrow Mesenchymal Stem Cell Therapy in Acute-on-chronic Liver Failure Phase 1